Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection
Dr. Reddy’s, will focus its resources and capabilities on its key therapy spaces of gastroenterology, pain management, cold and flu, allergy, oncology, neurology, paediatrics and women’s health as the Russia and CIS region continues to be a strong performer for the company
Evonik invests in start-up to improve patient recovery after open-chest surgery
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy
The first patient in India treated at Jaslok Hospital and Research Centre, Mumbai Includes the world’s smallest implantable spinal cord stimulator
Rimegepant is the first oral calcitonin gene-related peptide receptor antagonist to demonstrate positive results in a pivotal trial in the Asia Pacific
Dr. Reddy’s to promote and distribute select Novartis products including the Voveran range, the Calcium range and Methergine in India
It will showcase the company’s latest technologies in robotics, digital health and orthopaedic implants
The Ayurveda storefront will enhance visibility of unique Ayurveda products from Indian small businesses and D2C brands
Adds five years of market exclusivity on approval
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
